정형외과 연조직 수복 시장 규모, 점유율, 동향 분석 리포트 : 용도별, 손상 부위별, 지역별, 부문 예측(2024-2030년)

Orthopedic Soft Tissue Repair Market Growth & Trends:

The global orthopedic soft tissue repair market size is expected to reach USD 11.86 billion by 2030, registering a CAGR of 8.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising incidence of soft tissue injuries globally is one of the major market drivers. For instance, according to the Healon Health article, about 628,000 people sprain their ankles annually, whereas ankle sprains are the most common sports-related injury. In addition, a John Hopkins Medicine article states that approximately 30 million individuals engage in organized sports in the U.S., leading to over 3.5 million injuries annually.

The growing preference for secure and uncomplicated long-term surgical procedures and an increasing number of individuals adopting active lifestyles fuel the demand for the market. Furthermore, the popularity of vigorous, energetic sports such as football, soccer, and basketball has significantly increased soft tissue injuries. According to National Safety Council statistics, in 2022, nearly 3.6 million individuals went through serious emergency injuries caused by sports and recreational activities. Some key factors contributing to the expansion of the market include an aging population, rising obesity rates, and advancements in medical technology.

The growing technological advancements and research in studying novel components and soft tissue repair mechanisms, such as innovative surgical techniques, bioresorbable materials for patches, wound healing or suture anchors, and fixation devices, are helping to stabilize and support bones during their recovery process following surgery or injury. These devices cater to a range of conditions, such as fractures and sports injuries, and help in primary anterior cruciate ligament (ACL) tear repair.

For instance, in August 2022, CONMED acquired Biorez, Inc., a medical device manufacturer. This acquisition focuses on the advanced healing of soft tissue using its patented BioBrace implant technology and acquiring bioinductive collagen scaffold technology applied in sports medicine.

Orthopedic Soft Tissue Repair Market Report Highlights:

• Based on application, cruciate ligament repair accounted for the largest market share in 2023. This is attributable to the rising number of injuries in sports and recreational activities. In contrast, ACL tear is the most prevalent injury among athletes, further propelling the demand for improved soft tissue repair procedures
• Based on injury location, knee dominated the market in 2023 owing to knee soft tissue injuries accounting for 10-25% of all sports-related injuries. Soft tissue injuries in the knee can include strains, sprains, and contusions, often occurring in sports that involve running, jumping, or rapid changes in direction, like soccer, basketball, and football
• North America dominated the global market with the highest revenue share due to the presence of key market players focusing on launching novel techniques and products. Furthermore, rising healthcare expenditures, reimbursement plans, and investments in healthcare infrastructure are aimed at making soft tissue surgeries affordable in the region

Table of Contents

Chapter 1 Orthopedic Soft Tissue Repair Market: Methodology and Scope

• 1.1 Research Process
• 1.2 Information Procurement
  • 1.2.1 Purchased database:
    • 1.2.1.1 GVR's internal database
  • 1.2.2 Market Formulation & Validation
• 1.3 Research Methodology
• 1.4 Research Scope and Assumptions
• 1.5 Research Methodology
  • 1.5.1 Region Market: Cagr Calculation
  • 1.5.2 Region Based Segment Share Calculation
• 1.6 List to Data Application

Chapter 2 Orthopedic Soft Tissue Repair Market: Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights
• 2.4 Orthopedic Soft Tissue Repair Market Snapshot

Chapter 3 Orthopedic Soft Tissue Repair Market: Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration And Growth Prospect Mapping
• 3.3 Market Variable Analysis
  • 3.3.1 Market Driver Analysis
  • 3.3.2 Market Restraint Analysis
  • 3.3.3 Industry Challenges
  • 3.3.4 Market Opportunity
• 3.4 Orthopedic Soft Tissue Repair Market: Analysis Tools
  • 3.4.1 Porter's Five Forces Analysis
    • 3.4.1.1 Bargaining Power Of Suppliers
    • 3.4.1.2 Bargaining Power Of Buyers
    • 3.4.1.3 Threat Of Substitution
    • 3.4.1.4 Threat Of New Entrants
    • 3.4.1.5 Competitive Rivalry
  • 3.4.2 Pestel Analysis
    • 3.4.2.1 Political Landscape
    • 3.4.2.2 Economic Landscape
    • 3.4.2.3 Social Landscape
    • 3.4.2.4 Technology Landscape
• 3.5 Major Deals & Strategic Alliances Analysis
  • 3.5.1 Mergers & Acquisitions
  • 3.5.2 Technological Collaboration
  • 3.5.3 Partnerships
  • 3.5.4 Licensing Agreements
• 3.6 Technology overview (qualitative analysis: current and future aspects)
• 3.7 Impact of COVID-19 on Orthopedic Soft Tissue Repair Market

Chapter 4. Orthopedic Soft Tissue Repair Market Segment Analysis, By Application

• 4.1. Application Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Orthopedic Soft Tissue Repair Market, by Application, 2018 to 2030
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Rotator Cuff Repair
    • 4.4.1.1. Rotator cuff repair market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Epicondylitis
    • 4.4.2.1. Epicondylitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Achilles Tendinosis Repair
    • 4.4.3.1. Achilles tendinosis repair market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Pelvic Organ Prolapse
    • 4.4.4.1. Pelvic organ prolapse market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Gluteal Tendon Repair
    • 4.4.5.1. Gluteal tendon repair market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.6. Cruciate Ligaments Repair
    • 4.4.6.1. Cruciate ligaments repair market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.7. Hip Arthroscopy
    • 4.4.7.1. Hip arthroscopy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.8. Biceps Tenodesis
    • 4.4.8.1. Biceps tenodesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.9. Others
    • 4.4.9.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Orthopedic Soft Tissue Repair Market Segment Analysis, By Injury Location

• 5.1. Injury Location Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Orthopedic Soft Tissue Repair Market, by Injury Location, 2018 to 2030
• 5.4. Knee
  • 5.4.1. Knee market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Shoulder
  • 5.5.1. Shoulder market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Hip
  • 5.6.1. Hip market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. Small Joints
  • 5.7.1. Small joints market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Orthopedic Soft Tissue Repair Market Segment Analysis, By Region, By Application, By Injury Location

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Orthopedic Soft Tissue Repair Market Share by Region, 2023 & 2030:
• 6.5. North America
  • 6.5.1. North America orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. U.S. orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Canada orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. UK orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Germany orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. France orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Italy orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Spain orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Norway orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Sweden orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Denmark orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Japan orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. China orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. India orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Australia orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. South Korea orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Thailand orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Brazil orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.8.2. Mexico
    • 6.8.2.1. Mexico orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Argentina orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. South Africa orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Saudi Arabia orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. UAE orthopedic soft tissue repair market, 2018 - 2030 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Kuwait orthopedic soft tissue repair market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Profiles
  • 7.3.1. Integra LifeSciences Corporation
    • 7.3.1.1. Company overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Application benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. Arthrex, Inc.
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Application benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Zimmer Biomet
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Application benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. DePuy Synthes
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Application benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Stryker Corporation
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Application benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. WRIGHT MEDICAL GROUP N.V.
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Application benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. ConMed Linvatec
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Application benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Smith & Nephew
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Application benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Boston Scientific Corporation
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Application benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. B. Braun SE
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Application benchmarking
    • 7.3.10.4. Strategic initiatives